Haleon's EPS Beat Is Reassuring -- Market Talk

Dow Jones

Feb 27, 2025

1014 GMT - Haleon's earnings-per-share beat signals an turning point, Barclays analysts say in a note. The British consumer-health giant's historical lack of EPS delivery has been a key investor complaint which should ease now after its 2H topped consensus by 6%, Barclays says. "Given recent strength in Haleon's share price we could see some profit taking first thing this morning, but the robust topline and EPS delivery confirm our thesis that Haleon is establishing a track record as a steady compounder," the analysts say. Haleon's 2025 guidance is in line with expectations, but its 2H weighting comes as a surprise, they add. Shares are down 3.1% at 38.33 pounds. (helena.smolak@wsj.com)

(END) Dow Jones Newswires

February 27, 2025 05:14 ET (10:14 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2514871963"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2514871963\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2514871963?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-27 18:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2514871963","market":"us","top_or_hot":-1,"title":"Haleon's EPS Beat Is Reassuring -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1014 GMT - <a href=\"https://laohu8.com/S/HLN\">Haleon</a>'s earnings-per-share beat signals an turning point, Barclays analysts say in a note. The British consumer-health giant's historical lack of EPS delivery has been a key investor complaint which should ease now after its 2H topped consensus by 6%, Barclays says. \"Given recent strength in Haleon's share price we could see some profit taking first thing this morning, but the robust topline and EPS delivery confirm our thesis that Haleon is establishing a track record as a steady compounder,\" the analysts say. Haleon's 2025 guidance is in line with expectations, but its 2H weighting comes as a surprise, they add. Shares are down 3.1% at 38.33 pounds. (helena.smolak@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 27, 2025 05:14 ET (10:14 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Haleon's EPS Beat Is Reassuring -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHaleon's EPS Beat Is Reassuring -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-02-27 18:14</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1014 GMT - <a href=\"https://laohu8.com/S/HLN\">Haleon</a>'s earnings-per-share beat signals an turning point, Barclays analysts say in a note. The British consumer-health giant's historical lack of EPS delivery has been a key investor complaint which should ease now after its 2H topped consensus by 6%, Barclays says. \"Given recent strength in Haleon's share price we could see some profit taking first thing this morning, but the robust topline and EPS delivery confirm our thesis that Haleon is establishing a track record as a steady compounder,\" the analysts say. Haleon's 2025 guidance is in line with expectations, but its 2H weighting comes as a surprise, they add. Shares are down 3.1% at 38.33 pounds. (helena.smolak@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 27, 2025 05:14 ET (10:14 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HLN","symbol_name":"Haleon","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2514871963","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2514871963","pubTimestamp":1740651240,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"1014 GMT - Haleon's earnings-per-share beat signals an turning point, Barclays analysts say in a note. The British consumer-health giant's historical lack of EPS delivery has been a key investor complaint which should ease now after its 2H topped consensus by 6%, Barclays says. \"Given recent strength in Haleon's share price we could see some profit taking first thing this morning, but the robust topline and EPS delivery confirm our thesis that Haleon is establishing a track record as a steady compounder,\" the analysts say. Haleon's 2025 guidance is in line with expectations, but its 2H weighting comes as a surprise, they add. Shares are down 3.1% at 38.33 pounds. ","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"HLN":"Haleon"},"translate_title":"Haleon的每股收益增长令人放心——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HLN":1},"content_text":"1014 GMT - Haleon's earnings-per-share beat signals an turning point, Barclays analysts say in a note. The British consumer-health giant's historical lack of EPS delivery has been a key investor complaint which should ease now after its 2H topped consensus by 6%, Barclays says. \"Given recent strength in Haleon's share price we could see some profit taking first thing this morning, but the robust topline and EPS delivery confirm our thesis that Haleon is establishing a track record as a steady compounder,\" the analysts say. Haleon's 2025 guidance is in line with expectations, but its 2H weighting comes as a surprise, they add. Shares are down 3.1% at 38.33 pounds. (helena.smolak@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 27, 2025 05:14 ET (10:14 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}